# SEREVENT
> **NDA020692** · New Drug Application · Sponsor: GLAXOSMITHKLINE · Approved 1997-09-19
## Drug
- **FDA Application Number:** NDA020692
- **Application type:** New Drug Application
- **Brand name:** SEREVENT
- **Generic name:** SALMETEROL XINAFOATE
- **Active ingredients:** SALMETEROL XINAFOATE
- **Dosage form:** POWDER
- **Route:** INHALATION
- **Marketing status:** Prescription
- **Sponsor:** GLAXOSMITHKLINE
- **Manufacturer:** GlaxoSmithKline LLC
- **First approval:** 1997-09-19
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020692)
---
*AI Analytics · CC0 1.0*